Somatuline Depot (lanreotide) Injection
IPSEN SOMATULINE DEPOT
Somatuline Depot is a sustained release formulation of lanreotide acetate.
Indications
SOMATULINE DEPOT is indicated for the long term treatment of individuals with acromegaly when the circulating levels of Growth Hormone (GH) and/or Insulin-like Growth Factor-1 (IGF-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatment. The goal of treatment in acromegaly is to reduce GH and IGF-1 levels and where possible to normalise these values.
SOMATULINE DEPOT is indicated for the relief of symptoms associated with acromegaly.
SOMATULINE DEPOT is also indicated for the treatment of symptoms associated with carcinoid tumours.
Source: Ipsen Pharma http://www.ipsen.ie/ipsen_product_autogel.html
Welcome to AcromegalyLive.TV
The Big Man
8 Apr, 2009
I understand this to be a breakthrough!
Thanks for posting this.
John Doe
11 May, 2009
Hey, I kind of like this theme!
jstrampel
13 May, 2009
This is a huge breakthrough, there are many therapeutic advances in somatostatin analogs for the management of patients with acromegaly and/or neuroendocrine tumors!